USD10
RXRX Shares
About Recursion PharmaceuticalsRecursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
USD10
RXRX Shares
About Recursion PharmaceuticalsRecursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Stats
TRADING WINDOW
Closed
OPENS AT
Aug 10 at 1:30 PM GMT+0
MARKET CAP
$1.67B
OPEN PRICE
Not enough data
LOW (1Y)
$3.54
HIGH (1Y)
$12.36
LOW (24H)
$3.18
HIGH (24H)
$3.24
VOLUME (24H)
$108.85K
98.86%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $3.18 | |
1 Week | $2.98 | |
1 Month | $3.72 | |
1 Year | $5.29 |
Past performance is not a reliable indicator of future results.
Discover more
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.